813 results on '"Hwang, Jimmy"'
Search Results
2. Molecular Characterization of KRAS Wild-type Tumors in Patients with Pancreatic Adenocarcinoma.
3. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer
4. Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling.
5. Evaluation of disseminated tumor cells and circulating tumor cells in patients with breast cancer receiving adjuvant zoledronic acid.
6. COVID-19 vaccine uptake trends in SARS-CoV-2 previously infected cancer patients
7. Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study
8. Predicting response to neoadjuvant chemotherapy for colorectal liver metastasis using deep learning on prechemotherapy cross‐sectional imaging
9. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer
10. Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
11. Genomic analysis of oesophageal carcinoma (EC) to identify recurrent mutations in histone methyltransferases as a distinctive subset.
12. Germline testing in patients with early-onset pancreatic cancer (EOPC).
13. Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer
14. Early-onset pancreatic cancer: an institutional series evaluating end-of-life care
15. Early mixed chimerism‐based preemptive immunotherapy in children undergoing allogeneic hematopoietic stem cell transplantation for acute leukemia
16. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy
17. Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
18. The challenge of measuring intra-individual change in fatigue during cancer treatment
19. Long-term survival in AIDS-related primary central nervous system lymphoma
20. Clinical outcomes in metastatic uveal melanoma treated with PD‐1 and PD‐L1 antibodies
21. Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
22. A portable survivorship care plan: a tool that helps educate and improve knowledge in childhood cancer survivors
23. Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer Center.
24. Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
25. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls
26. Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated Cancers
27. Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients
28. Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies.
29. Incidence of Non–Small-Cell Lung Cancer among California Hispanics According to Neighborhood Socioeconomic Status
30. Phase II study of irinotecan and temozolomide in breast cancer patients with progressing central nervous system disease
31. Healthy Colon, Healthy Life (Colon Sano, Vida Sana): Colorectal Cancer Screening Among Latinos in Santa Clara, California
32. Addressing barriers to increased adoption of DPYD genotyping at a large multisite cancer center
33. Supplementary Table S2 from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
34. Supplementary Figure 2 from Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
35. Data from Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers
36. Data from Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
37. Data from Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1+/− Humans and Mice
38. Supplementary Figure 1 from Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
39. Figure S2 from Molecular Characterization of Appendiceal Goblet Cell Carcinoid
40. Supplementary appendix from Molecular Characterization of Appendiceal Goblet Cell Carcinoid
41. Supplemental Figure 1 from Association of Homologous Recombination–DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers
42. Perspectives on this Article from Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1+/− Humans and Mice
43. Table S2 from Molecular Characterization of Appendiceal Goblet Cell Carcinoid
44. Supplementary Figure Legend from Association of Homologous Recombination–DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers
45. Data from Association of Homologous Recombination–DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers
46. CA 19-9 Response: A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma
47. Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation
48. A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
49. Figure S5 from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
50. Supplementary Methods from The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.